methoxyhydroxyphenylglycol has been researched along with brofaromine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| den Boer, JA; van Vliet, IM; Westenberg, HG | 1 |
| Antonin, KH; Bieck, PR; Firkusny, L; Nilsson, E; Schick, C; Schulz, R; Schwenk, M; Wollmann, H | 1 |
| Baumann, PA; Bernasconi, R; Buech, O; Delini-Stula, A; Felner, AE; Sigg, K; Waldmeier, PC | 1 |
| Antonin, KH; Bieck, PR; Gleiter, CH; Mühlbauer, B; Nilsson, E; Schulz, RM | 1 |
| Den Boer, JA; Slaap, BR; van Vliet, IM; Westenberg, HG | 1 |
2 trial(s) available for methoxyhydroxyphenylglycol and brofaromine
| Article | Year |
|---|---|
Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor.
Topics: Adult; Blood Pressure; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Melatonin; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Phobic Disorders; Piperidines; Psychiatric Status Rating Scales | 1992 |
MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report.
Topics: Adult; Biomarkers; Blood Pressure; Double-Blind Method; Female; Fluvoxamine; Heart Rate; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Panic Disorder; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 1996 |
3 other study(ies) available for methoxyhydroxyphenylglycol and brofaromine
| Article | Year |
|---|---|
Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
Topics: Adult; Biological Availability; Blood Pressure; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Phenelzine; Piperidines; Tryptamines; Tyramine; Vanilmandelic Acid | 1989 |
Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Brain Chemistry; Female; Hemodynamics; Hydroxyindoleacetic Acid; Liver; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Piperidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Synaptosomes; Tranylcypromine | 1983 |
Monoamine oxidase inhibition by the MAO-A inhibitors brofaromine and clorgyline in healthy volunteers.
Topics: Administration, Oral; Adult; Blood Pressure; Clorgyline; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Hypertension; Infusions, Intravenous; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Norepinephrine; Piperidines; Reference Values; Tryptamines; Tyramine | 1994 |